STERIS plc Stock News

Beyond analysts' top -and-bottom-line estimates for Steris (STE), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e

DUBLIN, IRELAND, Oct. 24, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 second qu

On the capital equipment side for STERIS (STE), the easing of supply-chain issues and reduced lead times are boosting shipments.

STERIS' (STE) healthcare segment benefits from procedure recovery, boosting investors' optimism.

Investors prioritize dividends for outperformance. List of upcoming dividend increases with at least 5 years of consistent growth. Historical returns of dividend stocks compared to benchmark ETF.

DUBLIN, IRELAND , Aug. 30, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Healthcare Conference in New York City

Investors are optimistic about STERIS' (STE) successful integration of the recently-acquired business and raised guidance.

Barring Life Sciences and Dental, rest of STERIS (STE) operating segments report organic revenue growth in fiscal Q1.

Steris (STE) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.86 per share. This compares to earnings of $1.90 per share a year ago.

Medical equipment provider Steris on Tuesday raised its profit forecast for fiscal 2024 after strength in its core healthcare business boosted first-quarter results above Wall Street estimates.

A financial advisor can help you understand the advantages and disadvantages of investment properties.

Investors may keep a tab on stocks like RCI, STE, AMP and CNI, which have lately hiked their dividend payments.

DUBLIN, IRELAND, July 19, 2023 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 first qua

STERIS (STE) announces the buyout of surgical instrumentation assets from Becton, Dickinson and Company in a $540 million transaction.

Becton, Dickinson and Co. (BD) BDX, +0.96% said Tuesday it agreed to sell its surgical instrumentation platform to Steris for STE, +0.04% for $540 million, or about 3.2 times the annual revenue of $17